Classification of ambiguous mutations in DNA mismatch repair genes identified in a population‐based study of colorectal cancer

Identification of germline mutations in DNA mismatch repair genes in colorectal cancer probands without an extensive family history can be problematic when ascribing relevance to cancer causation. We undertook a structured assessment of the disease‐causing potential of sequence variants identified in a prospective, population‐based study of 932 colorectal cancer patients, diagnosed at <55 years of age. Patient samples were screened for germline mutations in MLH1, MSH2, and MSH6. Of 110 carriers, 74 (67%) had one of 33 rare variants of uncertain pathogenicity (12 MLH1, 11 MSH2, and 10 MSH6). Pathogenicity was assessed by determining segregation in families, allele frequency in large numbers of unaffected controls, effect on mRNA for putative splice‐site mutations, effect on protein function by bioinformatic analysis and tumor microsatellite instability (MSI) status and DNA mismatch repair protein expression by immunohistochemistry. Because of the ambiguous nature of these variants and lack of concordance between functional assays and control allele frequency, we devised a scoring system to rank the degree of support for a pathogenic role. MLH1 c.200G>A p.G67E, MLH1 c.2041G>A p.A681T, and MSH2 c.2634+5G>C were categorized as pathogenic through assimilation of all available data, while 14 variants were categorized as benign (seven MLH1, three MSH2, and four MSH6). Interestingly, there is tentative evidence suggesting a possible protective effect of three variants (MLH1 c.2066A>G pQ689R, c.2146G>A p.V716M, and MSH2 c.965G>A p.G322D). These findings support a causal link with colorectal cancer for several DNA mismatch repair gene variants. However, the majority of missense changes are likely to be inconsequential polymorphisms. Hum Mutat 29(3), 367–374, 2008. © 2007 Wiley‐Liss, Inc.

[1]  A. Millar,et al.  Do MSH6 mutations contribute to double primary cancers of the colorectum and endometrium? , 2000, Human Genetics.

[2]  C. Ishioka,et al.  Functional analysis of human MLH1 variants using yeast and in vitro mismatch repair assays. , 2007, Cancer research.

[3]  K. Kinzler,et al.  Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. , 2007, Journal of the National Cancer Institute.

[4]  P. Radice,et al.  A human cell-based assay to evaluate the effects of alterations in the MLH1 mismatch repair gene. , 2006, Cancer research.

[5]  A. Viel,et al.  Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features , 2006, European Journal of Human Genetics.

[6]  Harry Campbell,et al.  Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. , 2006, The New England journal of medicine.

[7]  J. Stockman.  Screening for the Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) , 2006 .

[8]  J. Godino,et al.  Low prevalence of germline hMSH6 mutations in colorectal cancer families from Spain. , 2005, World journal of gastroenterology.

[9]  A. de la Chapelle,et al.  Functional significance and clinical phenotype of nontruncating mismatch repair variants of MLH1. , 2005, Gastroenterology.

[10]  H C van Houwelingen,et al.  Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment , 2005, Journal of Medical Genetics.

[11]  F. Collins,et al.  The MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer , 2004, Nature Genetics.

[12]  Hideyuki Suzuki,et al.  A yeast two-hybrid assay provides a simple way to evaluate the vast majority of hMLH1 germ-line mutations. , 2003, Cancer research.

[13]  T. Raevaara,et al.  Functional analysis of MSH6 mutations linked to kindreds with putative hereditary non-polyposis colorectal cancer syndrome. , 2002, Human molecular genetics.

[14]  C. Cruz,et al.  Pathogenicity of missense and splice site mutations in hMSH2 and hMLH1 mismatch repair genes: implications for genetic testing , 2002, Gut.

[15]  M. D'urso,et al.  Functional analysis of MLH1 mutations linked to hereditary nonpolyposis colon cancer , 2002, Genes, chromosomes & cancer.

[16]  H. Hollema,et al.  Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant. , 2002, American journal of human genetics.

[17]  D. Aust,et al.  Sixteen rare sequence variants of the hMLH1 and hMSH2 genes found in a cohort of 254 suspected HNPCC (hereditary non-polyposis colorectal cancer) patients: mutations or polymorphisms? , 2001, European journal of medical research.

[18]  M. Leppert,et al.  The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. , 2001, Gastroenterology.

[19]  A. Ellison,et al.  Functional analysis of human MLH1 and MSH2 missense variants and hybrid human-yeast MLH1 proteins in Saccharomyces cerevisiae. , 2001, Human molecular genetics.

[20]  R. Fishel,et al.  The Interaction of DNA Mismatch Repair Proteins with Human Exonuclease I* , 2001, The Journal of Biological Chemistry.

[21]  S. Henikoff,et al.  Predicting deleterious amino acid substitutions. , 2001, Genome research.

[22]  J. Kładny,et al.  Optimization of experimental conditions for RNA‐based sequencing of MLH1 and MSH2 genes , 2001, Human mutation.

[23]  M. Kohonen-Corish,et al.  Evaluation of enzymatic mutation detection™ in hereditary nonpolyposis colorectal cancer , 2000 .

[24]  J. Pignon,et al.  Extensive molecular screening for hereditary non-polyposis colorectal cancer , 2000, British Journal of Cancer.

[25]  M. Kohonen-Corish,et al.  Evaluation of enzymatic mutation detectiontrade mark in hereditary nonpolyposis colorectal cancer. , 2000, Human mutation.

[26]  H. Hollema,et al.  Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. , 1999, American journal of human genetics.

[27]  J. Tytell,et al.  Germ-line msh6 mutations in colorectal cancer families. , 1999, Cancer research.

[28]  P. Møller,et al.  Familial endometrial cancer in female carriers of MSH6 germline mutations , 1999, Nature Genetics.

[29]  Alessandra Viel,et al.  Assessment of pathogenicity criteria for constitutional missense mutations of the hereditary nonpolyposis colorectal cancer genes MLH1 and MSH2 , 1999, European Journal of Human Genetics.

[30]  T. Kunkel,et al.  Mutator phenotypes of common polymorphisms and missense mutations in MSH2 , 1999, Current Biology.

[31]  J. Saurin,et al.  Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancer , 1999, Human Genetics.

[32]  J. Garber,et al.  Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition testing. , 1999, JAMA.

[33]  R. Scott,et al.  Influence of selection criteria on mutation detection in patients with hereditary nonpolyposis colorectal cancer , 1999, Cancer.

[34]  T. Kunkel,et al.  Mutator Phenotypes Conferred by MLH1Overexpression and by Heterozygosity for mlh1Mutations , 1999, Molecular and Cellular Biology.

[35]  R. Fishel,et al.  The Interaction of the Human MutL Homologues in Hereditary Nonpolyposis Colon Cancer* , 1999, The Journal of Biological Chemistry.

[36]  A. Lindblom,et al.  Missense mutations in hMLH1 associated with colorectal cancer , 1999, Human Genetics.

[37]  S Srivastava,et al.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.

[38]  H. Grönberg,et al.  MSH2 codon 322 Gly to Asp seems not to confer an increased risk for colorectal cancer susceptibility. , 1998, European journal of cancer.

[39]  D. Robbins,et al.  Systematic analysis of hMSH2 and hMLH1 in young colon cancer patients and controls. , 1998, American journal of human genetics.

[40]  S. Friend,et al.  Functional analysis of human MLH1 mutations in Saccharomyces cerevisiae , 1998, Nature Genetics.

[41]  J. Herman,et al.  Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[42]  L. Aaltonen,et al.  Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. , 1998, The New England journal of medicine.

[43]  A. Viel,et al.  MLH1 and MSH2 constitutinal mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer , 1998, International journal of cancer.

[44]  C. Boland,et al.  A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. , 1997, Journal of the National Cancer Institute.

[45]  Y. Yuasa,et al.  Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. , 1997, Cancer research.

[46]  T. Prolla,et al.  Functional domains of the Saccharomyces cerevisiae Mlh1p and Pms1p DNA mismatch repair proteins and their relevance to human hereditary nonpolyposis colorectal cancer-associated mutations , 1997, Molecular and cellular biology.

[47]  P. Goodfellow,et al.  Mutational analysis of MLH1 and MSH2 in 25 prospectively‐acquired RER+ endometrial cancers , 1997, Genes, chromosomes & cancer.

[48]  J. Ivanovich,et al.  Mutations in MLH1 are more frequent than in MSH2 in sporadic colorectal cancers with microsatellite instability , 1997, Genes, chromosomes & cancer.

[49]  Yusuke Nakamura,et al.  Mutational analysis of the hMLH1 gene using an automated two‐dimensional DNA typing system , 1997, Human mutation.

[50]  A D Carothers,et al.  Cancer risk associated with germline DNA mismatch repair gene mutations. , 1997, Human molecular genetics.

[51]  T. Frebourg,et al.  Identification of novel germline hMLH1 mutations including a 22 kb Alu-mediated deletion in patients with familial colorectal cancer. , 1996, Cancer research.

[52]  B. Ponder,et al.  Mutation screening of MSH2 and MLH1 mRNA in hereditary non-polyposis colon cancer syndrome. , 1996, Journal of medical genetics.

[53]  R. Fodde,et al.  Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. , 1996, Gastroenterology.

[54]  R. Fleischmann,et al.  Mutation of a mutL homolog in hereditary colon cancer. , 1994, Science.

[55]  D. Ward,et al.  Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancer , 1994, Nature.

[56]  Robin J. Leach,et al.  Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer , 1993, Cell.

[57]  N. Copeland,et al.  The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. , 1993, Cell.

[58]  J. Mecklin,et al.  The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) , 1991, Diseases of the colon and rectum.